Package Label.Principal Display Panel
NDC 70771-1471-3
Deferasirox tablets, 90 mg
30 Tablets
Rx only
NDC 70771-1472-3
Deferasirox tablets, 180 mg
30 Tablets
Rx only
NDC 70771-1473-3
Deferasirox tablets, 360 mg
30 Tablets
Rx only
The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Deferasirox (NDC 70771-1473). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1471-3
Deferasirox tablets, 90 mg
30 Tablets
Rx only
NDC 70771-1472-3
Deferasirox tablets, 180 mg
30 Tablets
Rx only
NDC 70771-1473-3
Deferasirox tablets, 360 mg
30 Tablets
Rx only
* Please review the disclaimer below.